Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, India.

by Sakib Burza, Prabhat K Sinha, Raman Mahajan, María Angeles Lima, Gaurab Mitra, Neena Verma, Manica Balasegaram, Pradeep Das
Published 2014-01-01

Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India.

by Sakib Burza, Prabhat K Sinha, Raman Mahajan, María Angeles Lima, Gaurab Mitra, Neena Verma, Manica Balasegaram, Pradeep Das
Published 2014-01-01

Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.

by Sakib Burza, Prabhat Kumar Sinha, Raman Mahajan, Marta González Sanz, María Angeles Lima, Gaurab Mitra, Neena Verma, Pradeep Das
Published 2014-01-01

Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).

by Sakib Burza, Raman Mahajan, Prabhat K Sinha, Johan van Griensven, Krishna Pandey, María Angeles Lima, Marta Gonzalez Sanz, Temmy Sunyoto, Sunil Kumar, Gaurab Mitra, Ranjeet Kumar, Neena Verma, Pradeep Das
Published 2014-08-01